KMS Medisurgi board to meet on May 30 for FY26 results

1 min read     Updated on 23 May 2026, 03:05 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

KMS Medisurgi Limited will hold a board meeting on May 30, 2026, to approve the standalone audited financial results for the year ended March 31, 2026. The trading window for the company's shares remains closed until 48 hours after the results are disclosed.

powered bylight_fuzz_icon
41074541

*this image is generated using AI for illustrative purposes only.

KMS Medisurgi Limited has announced that its board of directors will meet on Saturday, May 30, 2026, to discuss the company's financial performance for the fiscal year ending March 31, 2026. The meeting is scheduled to take place at 02:00 pm at the registered office located at 297/301, Ground Floor, May Building, Princess Street, Marine Lines (East), Mumbai 400 002.

Agenda for the Meeting

The primary agenda for the upcoming board meeting is to consider and approve the standalone audited financial results for the year ended March 31, 2026. The board will also discuss any other business items with the permission of the chairman.

Trading Window Closure

In accordance with the Company’s Code of Conduct for the prevention of Insider Trading, the trading window for dealing in the equity shares of the company has been closed since April 01, 2026. This restriction will remain in effect until 48 hours after the communication of the financial results to the stock exchanges.

Meeting Details

Detail Information
Date May 30, 2026
Time 02:00 pm
Location Registered Office, Mumbai
Purpose Consideration of FY26 Audited Results

Historical Stock Returns for KMS Medisurgi

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%+4.98%+4.65%+290.59%

How does KMS Medisurgi's FY26 revenue and profitability compare to its FY25 performance, and what growth trajectory can investors expect going forward?

Will the board announce any dividend distribution or capital allocation plans alongside the FY26 audited results?

How has KMS Medisurgi's stock price reacted historically following its annual results announcements, and what analyst expectations are priced in ahead of this meeting?

KMS Medisurgi Independent Director Mr. Pratik Pravin Tarpara Steps Down After Completion of First Term

1 min read     Updated on 08 May 2026, 02:56 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

KMS Medisurgi Limited has disclosed the cessation of Mr. Pratik Pravin Tarpara (DIN-08689556) as Independent Director, effective 30th September 2025, upon completion of his first term of appointment. The filing was made under Regulation 30 of the SEBI Listing Regulations. Mr. Tarpara held no directorships in other listed companies, and there are no board committee updates arising from the change. The Board acknowledged his contributions and guidance during his tenure.

powered bylight_fuzz_icon
39777990

*this image is generated using AI for illustrative purposes only.

KMS Medisurgi Limited has informed stock exchanges of the cessation of Mr. Pratik Pravin Tarpara (DIN-08689556) as an Independent Director of the company, effective 30th September 2025. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mr. Tarpara's departure follows the completion of his first term of appointment as an Independent Director.

Director Cessation Details

The company filed the disclosure in compliance with Clause 7 of Para A of Part A of Schedule III of the SEBI Listing Regulations, read with the SEBI Circular dated 13 July 2023, and the SEBI master circular dated November 11, 2024. The key details pertaining to the cessation are outlined below:

Parameter: Details
Name of Director: Mr. Pratik Pravin Tarpara
DIN: 08689556
Reason for Cessation: Completion of first term of appointment as Independent Director
Date of Cessation: 30th September 2025
Directorship in Other Listed Companies: Nil
Board Committee Update: Nil
Relationship Between Directors: Not Applicable

Board Acknowledgement

The Board of Directors and Management of KMS Medisurgi placed on record their deep appreciation for the invaluable contributions, guidance, and services rendered by Mr. Pratik Pravin Tarpara during his tenure as an Independent Director. The disclosure was signed by Siddharth Kanakia, Managing Director (DIN: 07595098), on behalf of the company from Mumbai.

Historical Stock Returns for KMS Medisurgi

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%+4.98%+4.65%+290.59%

Who will KMS Medisurgi appoint as a replacement Independent Director, and how might the new appointment affect the board's composition and governance structure?

How will the departure of Mr. Tarpara impact the quorum and functioning of key board committees such as the Audit or Nomination & Remuneration Committee at KMS Medisurgi?

Given the regulatory requirement for a minimum number of Independent Directors under SEBI norms, what is the timeline within which KMS Medisurgi must fill this vacancy to remain compliant?

More News on KMS Medisurgi

1 Year Returns:+4.65%